| review article | Q7318358 |
| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1092113228 |
| P356 | DOI | 10.1186/S40659-017-0139-2 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1186/s40659-017-0139-2 |
| P932 | PMC publication ID | 6389095 |
| P698 | PubMed publication ID | 28985766 |
| P50 | author | Patricio Gonzalez-Hormazabal | Q61086619 |
| P2093 | author name string | Lilian Jara | |
| Raul Godoy | |||
| Tomas de Mayo | |||
| Sebastian Morales | |||
| Valentina Carrasco | |||
| P2860 | cites work | Population-based estimate of the average age-specific cumulative risk of breast cancer for a defined set of protein-truncating mutations in BRCA1 and BRCA2. Australian Breast Cancer Family Study | Q73022855 |
| Prevalence and penetrance of BRCA1 and BRCA2 mutations in a population-based series of breast cancer cases. Anglian Breast Cancer Study Group | Q73108544 | ||
| Polygenic susceptibility to breast cancer and implications for prevention | Q78029012 | ||
| BRCA1 and BRCA2 mutation analysis of early-onset and familial breast cancer cases in Mexico | Q78545240 | ||
| Prevalence of BRCA1 and BRCA2 mutations in breast cancer patients from Brazil | Q79298338 | ||
| Absence of CHEK2 1100delC mutation in familial breast cancer cases from a South American population | Q81312515 | ||
| RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population | Q81340692 | ||
| MRI surveillance for hereditary breast-cancer risk | Q81776012 | ||
| Analysis of BRCA1 and BRCA2 mutations in Brazilian breast cancer patients with positive family history | Q82151956 | ||
| BRCA1 and BRCA2 mutations among ovarian cancer patients from Colombia | Q82294677 | ||
| Oncogenic pathways in hereditary and sporadic breast cancer | Q83813055 | ||
| The BARD1 Cys557Ser variant and risk of familial breast cancer in a South-American population | Q84035532 | ||
| BRCA1 and BRCA2 mutations among familial breast cancer patients from Costa Rica | Q84898545 | ||
| Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families | Q85064687 | ||
| Association of methylenetetrahydrofolate reductase and methionine synthase polymorphisms with breast cancer risk and interaction with folate, vitamin B6, and vitamin B 12 intakes | Q85303108 | ||
| Polymorphisms in GSTM1, GSTT1, GSTP1, and GSTM3 genes and breast cancer risk in northeastern Mexico | Q85497751 | ||
| Role of MTHFR C677T and MTR A2756G polymorphisms in thyroid and breast cancer development | Q89424114 | ||
| Detection of R337H, a germline TP53 mutation predisposing to multiple cancers, in asymptomatic women participating in a breast cancer screening program in Southern Brazil | Q56786129 | ||
| Breast cancer risk associated with gene expression and genotype polymorphisms of the folate-metabolizing MTHFR gene: a case-control study in a high altitude Ecuadorian mestizo population | Q57095251 | ||
| A common coding variant in CASP8 is associated with breast cancer risk | Q57250674 | ||
| Common variants on chromosome 5p12 confer susceptibility to estrogen receptor–positive breast cancer | Q57251792 | ||
| The emerging landscape of breast cancer susceptibility | Q57272203 | ||
| The genetic attributable risk of breast and ovarian cancer | Q71089065 | ||
| PALB2 is an integral component of the BRCA complex required for homologous recombination repair | Q24316113 | ||
| PALB2 regulates recombinational repair through chromatin association and oligomerization | Q24322952 | ||
| Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies | Q24531993 | ||
| Genome-wide association study identifies novel breast cancer susceptibility loci | Q24645441 | ||
| The first 30 years of p53: growing ever more complex | Q24645732 | ||
| Variation of breast cancer risk among BRCA1/2 carriers | Q24646346 | ||
| Interethnic admixture and the evolution of Latin American populations | Q26998589 | ||
| A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1 | Q28115843 | ||
| Gene admixture in the Costa Rican population | Q28205898 | ||
| RAD51 interacts with the evolutionarily conserved BRC motifs in the human breast cancer susceptibility gene brca2 | Q28257035 | ||
| Characterization of BRCA1 and BRCA2 mutations in a large United States sample | Q28383993 | ||
| Germline mutations in BRCA1, BRCA2, CHEK2 and TP53 in patients at high-risk for HBOC: characterizing a Northeast Brazilian Population | Q28389268 | ||
| Genomic Insights into the Ancestry and Demographic History of South America | Q29037184 | ||
| Cancer statistics, 2009 | Q29547625 | ||
| Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The Breast Cancer Linkage Consortium | Q29619206 | ||
| Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial | Q30080035 | ||
| BRCA2 BRC motifs bind RAD51-DNA filaments | Q30437059 | ||
| Impact of neonatal screening and surveillance for the TP53 R337H mutation on early detection of childhood adrenocortical tumors | Q30554353 | ||
| Association of common ATM variants with familial breast cancer in a South American population. | Q33330505 | ||
| Penetrance estimates for BRCA1 and BRCA2 based on genetic testing in a Clinical Cancer Genetics service setting: risks of breast/ovarian cancer quoted should reflect the cancer burden in the family | Q33338978 | ||
| Hereditary breast and ovarian cancer: assessment of point mutations and copy number variations in Brazilian patients | Q33684029 | ||
| Association between rs2981582 polymorphism in the FGFR2 gene and the risk of breast cancer in Mexican women | Q33724850 | ||
| Genetic admixture and population substructure in Guanacaste Costa Rica | Q33725471 | ||
| Prevalence of the TP53 p.R337H mutation in breast cancer patients in Brazil | Q33768942 | ||
| An inherited p53 mutation that contributes in a tissue-specific manner to pediatric adrenal cortical carcinoma | Q33930947 | ||
| Human genetics. The genetics of Mexico recapitulates Native American substructure and affects biomedical traits. | Q34041231 | ||
| Breast and ovarian cancer | Q34203363 | ||
| Breast cancer genetics: what we know and what we need | Q34236139 | ||
| Full-exon pyrosequencing screening of BRCA germline mutations in Mexican women with inherited breast and ovarian cancer | Q34288968 | ||
| Population-based screening for breast and ovarian cancer risk due to BRCA1 and BRCA2. | Q34314370 | ||
| Localization of a breast cancer susceptibility gene, BRCA2, to chromosome 13q12-13. | Q34334383 | ||
| Breast and ovarian cancer risks in a large series of clinically ascertained families with a high proportion of BRCA1 and BRCA2 Dutch founder mutations | Q44602623 | ||
| Methylenetetrahydrofolate reductase C677T and A1298C polymorphisms and colorectal cancer: the Fukuoka Colorectal Cancer Study | Q45152347 | ||
| Association of the highly prevalent TP53 R337H mutation with pediatric choroid plexus carcinoma and osteosarcoma in southeast Brazil | Q45174407 | ||
| BRCA1 and BRCA2 mutations in breast cancer patients from Venezuela. | Q45904167 | ||
| High proportion of BRCA1/2 founder mutations in Hispanic breast/ovarian cancer families from Colombia. | Q46002818 | ||
| The use of preventive measures among healthy women who carry a BRCA1 or BRCA2 mutation | Q46542512 | ||
| Association of genetic variants at TOX3, 2q35 and 8q24 with the risk of familial and early-onset breast cancer in a South-American population. | Q46762978 | ||
| Reduced mammographic density with use of a gonadotropin-releasing hormone agonist-based chemoprevention regimen in BRCA1 carriers | Q47582112 | ||
| Prevalence of BRCA1 and BRCA2 gene mutations in families with medium and high risk of breast and ovarian cancer in Brazil | Q47983920 | ||
| The TP53 mutation, R337H, is associated with Li-Fraumeni and Li-Fraumeni-like syndromes in Brazilian families. | Q48640561 | ||
| BRCA1 and BRCA2 germline mutations in Uruguayan breast and breast-ovarian cancer families. Identification of novel mutations and unclassified variants. | Q51525736 | ||
| Polymorphisms of the XRCC1 gene and breast cancer risk in the Mexican population. | Q54173735 | ||
| ATM polymorphisms IVS24-9delT, IVS38-8T>C, and 5557G>A in Mexican women with familial and/or early-onset breast cancer. | Q54338645 | ||
| Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population. | Q54466712 | ||
| Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype-phenotype correlations. | Q54633120 | ||
| BRCA1 and BRCA2: 1994 and beyond | Q34345297 | ||
| Control of BRCA2 cellular and clinical functions by a nuclear partner, PALB2. | Q34541051 | ||
| Comprehensive analysis of BRCA1, BRCA2 and TP53 germline mutation and tumor characterization: a portrait of early-onset breast cancer in Brazil | Q34613122 | ||
| Clinical and pathological characteristics of Hispanic BRCA-associated breast cancers in the American-Mexican border city of El Paso, TX. | Q34991306 | ||
| Significant clinical impact of recurrent BRCA1 and BRCA2 mutations in Mexico | Q35007651 | ||
| Association of PALB2 sequence variants with the risk of familial and early-onset breast cancer in a South-American population | Q35068734 | ||
| Detoxification of electrophilic compounds by glutathione S-transferase catalysis: determinants of individual response to chemical carcinogens and chemotherapeutic drugs? | Q35191137 | ||
| Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from Peru | Q35217775 | ||
| Recurrent BRCA1 and BRCA2 mutations in Mexican women with breast cancer | Q35830539 | ||
| Prevalence of the BRCA1 founder mutation c.5266dupin Brazilian individuals at-risk for the hereditary breast and ovarian cancer syndrome | Q35856408 | ||
| ATM signaling and genomic stability in response to DNA damage | Q35986624 | ||
| TP53 mutations as biomarkers for cancer epidemiology in Latin America: current knowledge and perspectives | Q36118841 | ||
| Use of statistics to assess the global burden of breast cancer | Q36375357 | ||
| Prediction of breast cancer risk based on profiling with common genetic variants | Q36583004 | ||
| The BOADICEA model of genetic susceptibility to breast and ovarian cancers: updates and extensions | Q36615665 | ||
| Genetic susceptibility for breast cancer: how many more genes to be found? | Q36820486 | ||
| Nordic collaborative study of the BARD1 Cys557Ser allele in 3956 patients with cancer: enrichment in familial BRCA1/BRCA2 mutation-negative breast cancer but not in other malignancies | Q36927115 | ||
| Clinical and molecular features associated with biallelic mutations in FANCD1/BRCA2. | Q37004481 | ||
| Early-onset breast cancer patients in the South and Southeast of Brazil should be tested for the TP53 p.R337H mutation | Q37011925 | ||
| BRCA1 and BRCA2 rearrangements in Brazilian individuals with Hereditary Breast and Ovarian Cancer Syndrome. | Q37011975 | ||
| Genome-wide linkage scan reveals three putative breast-cancer-susceptibility loci | Q37156098 | ||
| Associations between null mutations in GSTT1 and GSTM1, the GSTP1 Ile(105)Val polymorphism, and mortality in breast cancer survivors | Q37204995 | ||
| A genome wide linkage search for breast cancer susceptibility genes | Q37272982 | ||
| PALB2 links BRCA1 and BRCA2 in the DNA-damage response | Q37361223 | ||
| BARD1, a possible biomarker for breast and ovarian cancer | Q37644084 | ||
| Prevalence of BRCA1 and BRCA2 mutations in unselected breast cancer patients from medellín, Colombia | Q37721626 | ||
| The complex genetic landscape of familial breast cancer | Q38095764 | ||
| PALB2 functionally connects the breast cancer susceptibility proteins BRCA1 and BRCA2. | Q39827885 | ||
| Association of the GSTM1 null polymorphism with breast cancer in a Mexican population. | Q40357579 | ||
| Clinical follow up of mexican women with early onset of breast cancer and mutations in the BRCA1 and BRCA2 genes. | Q40423324 | ||
| The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds | Q41226231 | ||
| Spectrum of BRCA1/2 variants in 940 patients from Argentina including novel, deleterious and recurrent germline mutations: impact on healthcare and clinical practice | Q41694365 | ||
| Frequency of germline DNA genetic findings in an unselected prospective cohort of triple-negative breast cancer patients participating in a platinum-based neoadjuvant chemotherapy trial. | Q42491917 | ||
| Genetic polymorphisms of cytochrome P450 and glutathione S-transferase associated with antituberculosis drug-induced hepatotoxicity in Chinese tuberculosis patients | Q42916623 | ||
| Breast cancer risk, dietary intake, and methylenetetrahydrofolate reductase (MTHFR)single nucleotide polymorphisms | Q43086656 | ||
| Genomic rearrangements of the BRCA1 gene in Chilean breast cancer families: an MLPA analysis | Q43569224 | ||
| Polymorphisms of GSTM1 and GSTT1 genes in breast cancer susceptibility: a case-control study. | Q43792717 | ||
| The average cumulative risks of breast and ovarian cancer for carriers of mutations in BRCA1 and BRCA2 attending genetic counseling units in Spain | Q44540465 | ||
| P275 | copyright license | Creative Commons Attribution 4.0 International | Q20007257 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 1 | |
| P921 | main subject | ovarian cancer | Q172341 |
| breast neoplasm | Q23929670 | ||
| ovarian neoplasm | Q11793790 | ||
| mutation | Q42918 | ||
| genetic predisposition to disease | Q64843122 | ||
| P304 | page(s) | 35 | |
| P577 | publication date | 2017-10-06 | |
| P1433 | published in | Biological Research | Q2389484 |
| P1476 | title | Mutations in BRCA1, BRCA2 and other breast and ovarian cancer susceptibility genes in Central and South American populations | |
| P478 | volume | 50 |
| Q97066903 | Association of PIN3 16-bp duplication polymorphism of TP53 with breast cancer risk in Mali and a meta-analysis |
| Q64251583 | Genetic Epidemiology of Breast Cancer in Latin America |
| Q64238567 | Precision medicine for locally advanced breast cancer: frontiers and challenges in Latin America |
| Q96575982 | Sequencing technology status of BRCA1/2 testing in Latin American Countries |
| Q49874321 | Women with hereditary breast cancer predispositions should avoid using their smartphones, tablets, and laptops at night. |
Search more.